Summaries of Evidence

Evidence summaries aim to provide an informative and to the point overview of COVID-19. They are regularly updated to reflected the latest knowledge.

Links are checked regularly however please be aware that free access may be withdawn without notice.

NICE Rapid Summaries (free)

Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES23)

Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19

Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19

Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis

Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19

NICE Clinical Knowlege Summary (free)

Gives background information as well as covering diagnosis and management of COVID-19.

UpToDate (free)

Includes free access to their COVID-19 summary as well as summaries on acute respiratory distress, ventialtion and oxygenation and lots more.

Additional clinical topics:
Questions and answers: 

DynaMed (free)

Covers etiology and pathogenesis, diagnosis, management etc of COVID-19. The following topics are also available:

BMJ Best Pratice (free)

Information is divided into sections on theory, diagnosis, management and follow-up.

Oxford CEBM COVID-19 Evidence Service (free)

Evidence based summaries of COVID-19 relevant topics. 

Evidence Aid (free)

Evidence Aid work to summarise evidence that can help inform preparation for and response to disasters and emergencies. They are currently summarising systematic reviews that may help health services deal with the COVID-19 impact.